TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA secures contract for Call For Proposals Under Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M

Portugal, June 11 -- Portugal based TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA has secured contract from Unidade Local De Saude Tamega E Sousa, E.P.E. for Call For Proposals Under Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M . The value of the contract is worth 11354790.0 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....